文献速递胰腺与胆道疾病消化道肿瘤与早癌消化内镜

DNA甲基化标志物在ERCP刷检细胞学中提示胆管癌的诊断效能

Diagnostic power of DNA methylation markers suggestive of cholangiocarcinoma in ERCP-based brush cytology.
PubMed 文献 · Gastrointest Endosc · 2021-07-12

结果显示MI_H和MI_N的敏感性(95.1%和90.2%)和准确性(82.3%和89.5%)均高于刷检细胞学和CA19-9,联合检测敏感性达97.4%、准确性91.0%。

要点

  • MI_H和MI_N诊断胆管癌的敏感性分别为95.1%和90.2%,准确性分别为82.3%和89.5%。
  • 联合刷检细胞学、两种甲基化标志物和CA19-9可将敏感性提高至97.4%、准确性至91.0%。
  • 在细胞学和CA19-9均阴性的6例确诊胆管癌患者中,甲基化标志物在5例中呈阳性。

核心结论

  • DNA甲基化提高了胆管癌诊断的敏感性,在胆道狭窄患者中具有应用前景,但需未来验证研究评估其临床作用。

主要发现

  • MI_H和MI_N的敏感性分别为95.1%和90.2%,准确性分别为82.3%和89.5%,均高于刷检细胞学(61.5%和78.1%)和CA19-9(69.4%和77.8%)。
  • 联合刷检细胞学、两种甲基化标志物和CA19-9的敏感性为97.4%、准确性为91.0%。
  • 在细胞学和CA19-9均阴性的6例确诊胆管癌患者中,5例甲基化标志物阳性。

临床怎么用

  • 对于胆道狭窄患者,在常规刷检细胞学和CA19-9基础上联合HOXA1和NEUROG1启动子甲基化检测可能提高胆管癌诊断敏感性。

局限性

  • 结论需未来验证研究评估其临床实践中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Accurate differentiation between cholangiocarcinoma (CCA) and benign biliary stricture is of paramount importance. Biliary brush cytology is a simple and safe diagnostic approach that provides relatively high specificity; however, sensitivity is limited. Previous reports indicated the aberrations of DNA methylation in CCA. This study aimed to investigate the diagnostic performance of the methylation index (MI) of HOXA1 and NEUROG1 gene promoters in CCA. METHODS: Patients with biliary stricture who underwent ERCP with brush cytology in Siriraj Hospital from September 2016 to December 2019 were prospectively enrolled. The MI of HOXA1 (MI_H) and MI of NEUROG1 (MI_N) were determined by quantitative methylation-specific polymerase chain reaction. The diagnostic power for CCA was tested for MI from both genes and serum carbohydrate antigen 19-9 (CA19-9). RESULTS: Sixty-seven patients were included in the study; 41 patients had a final diagnosis of CCA, and 26 patients were determined to have a benign biliary stricture. The results showed that both MI_H and MI_N had higher sensitivity and accuracy (95.1% and 82.3% and 90.2% and 89.5%, respectively) than brush cytology (61.5% and 78.1%) and CA19-9 (69.4% and 77.8%). The combination of brush cytology, both methylation markers, and CA19-9 increased the sensitivity and accuracy to 97.4% and 91.0%. Methylation markers were positive in 5 of 6 patients with confirmed CCA whose cytology and CA19-9 were negative. CONCLUSIONS: DNA methylation increased the sensitivity for the diagnosis of CCA; therefore, the use of DNA methylation is promising for diagnosis of CCA in patients with biliary strictures. A future validation study is warranted to assess its role in clinical practice. (Clinical trial registration number: NCT04568512.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Prachayakul V, Rugivarodom M, Nopjaroonsri P, et al. Diagnostic power of DNA methylation markers suggestive of cholangiocarcinoma in ERCP-based brush cytology. Gastrointest Endosc. 2021. PMID: 34265285. doi:10.1016/j.gie.2021.07.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。